Moreover, intraperitoneal administration of escitalopram, a serotonin reuptake inhibitor mostly used for the treatment of major depression and general anxiety disorder, led to the downregulation of SPX mRNA in the hypothalamus and upregulated expression of SPX mRNA in the hippocampus and striatum in rats [23]. The gene discussed is SPX; the disease is major depressive disorder.